About
BeamMed develops, manufactures, and markets bone-related screening, diagnostic, and monitoring solutions. The company produces ultrasound technology and devices that enable physicians to provide early assessment, diagnosis, and monitoring of osteoporosis, as well as to assess bone growth. BeamMed's line of devices is based on the patented Omnipath axial transmission technology, a quantitative ultrasound technology that has been proven to offer a high level of accuracy and patient safety. The Sunlight Omnisense 9000 Quantitative Ultrasound Bone Sonometer delivers a fast, user-friendly assessment of osteoporosis, enabling cost-effective early assessment, diagnosis, and monitoring of the disease. The lightweight MiniOmni Quantitative Ultrasound device is a portable bone sonometer that also enables physicians to provide early assessment, diagnosis, and monitoring of osteoporosis. The MiniOmni meets the standard requirement of NCQA HEDIS OMW measure and is used by payers and providers in the United States to close HEDIS gaps and improve Medicare quality scores. The MiniOmni is used in primary care facilities such as clinics and checkup centers, as well as in home visits.
Funding history · 1 round · $4.0M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is BeamMed's core business?
- BeamMed develops, manufactures, and markets bone-related screening, diagnostic, and monitoring solutions using ultrasound technology to assess bone density and growth.
- When was BeamMed founded?
- BeamMed was founded in April 2004.
- What is the primary technology behind BeamMed's devices?
- BeamMed's devices are based on the patented Omnipath axial transmission technology, a quantitative ultrasound technology.
- What is one of BeamMed's key products for osteoporosis assessment?
- The Sunlight Omnisense 9000 Quantitative Ultrasound Bone Sonometer is one of BeamMed's products for early assessment, diagnosis, and monitoring of osteoporosis.
- Which BeamMed product is used by payers and providers in the United States to improve Medicare quality scores?
- The MiniOmni Quantitative Ultrasound device is used by payers and providers in the United States to close HEDIS gaps and improve Medicare quality scores.
- Where is BeamMed's headquarters located?
- BeamMed's headquarters is located in Petah Tikva, Israel.
- What was BeamMed's last known funding round?
- In May 2010, BeamMed raised an undisclosed round of $4,000,000 from D.N.A Biomedical Solutions Ltd.
- How many employees does BeamMed currently have?
- BeamMed currently has 15 employees.
- What was a recent upgrade BeamMed rolled out for its MiniOmni device?
- In May 2020, BeamMed rolled out a major and faster upgrade called "1-Cycle Express" for its MiniOmni Portable Bone Density Scanner.